AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2015
Dec 8, 2015
34576_dirs_2015-12-07_d0880190-a10c-439e-8ef8-c5e6105da799.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-12-04
Reporting Person: Rosenkranz Roberto Pedro (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-04 | Common Stock | M | 4000 | $2.90 | Acquired | 39000 | Direct |
| 2015-12-04 | Common Stock | M | 3000 | $5.95 | Acquired | 42000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-04 | Stock Option (Right to Buy) | $2.90 | M | 4000 | Disposed | 2020-04-27 | Common Stock (4000) | Direct |
| 2015-12-04 | Stock Option (Right to Buy) | $5.95 | M | 3000 | Disposed | 2022-06-27 | Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40 | Indirect |
Footnotes
F1: Fully vested.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10